Cell phenotype as a target of drug therapy in chronic inflammatory diseases

Medical Hypotheses

Volumn 54, Issue 2, 2000, Pages 193-197

  Shiels, I A ^a   Taylor, S M ^a   Fairlie, D P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID;

ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CHRONIC INFLAMMATION; DIABETES MELLITUS; INFLAMMATORY DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0034100563     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0017     Document Type: Article

References (31)

1. Borish L., Joseph B. Z. Inflammation and the allergic response. Med Clin North Am. 76:1992;765-787.
2. Owens M. W., Grisham M. B. Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation. Inflammation. 17:1993;481-487.
3. Chung K. F., Rogers D. F., Barnes P. J., Evans T. W. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J. 3:1990;329-337.
4. Black P. N., Young P. G., Skinner S. J. Response of airway smooth muscle cells to TGF-beta 1: effects on growth and synthesis of glycosaminoglycans. Am J Physiol. 271:1996;L910-L917.
5. Pauletto P., Chiavegato A., Giuriato L. Hyperplastic growth of aortic smooth muscle cells in renovascular hypertensive rabbits is characterized by the expansion of an immature cell phenotype. Circ Res. 74:1994;774-788.
6. Ruef C., Kashgarian M., Coleman D. L. Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion: Am J Pathol. 141:1992;429-439.
7. Devlin R. B., McKinnon K. P., Noah T., Becker S., Koren H. S. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am J Physiol. 266:1994;L612-L619.
8. Shiels I., Bowler S., Taylor S. Homologous serum increases fibronectin expression and cell adhesion in airway smooth muscle cells. Inflammation. 20:1996;373-387.
9. Sanders M. Molecular and cellular concepts in atherosclerosis. Pharmacol Ther. 61:1994;109-153.
10. Sakatsume M., Saito A., Takeda T. Mesangial cell-matrix interactions: modulation of matrix expression in mesangial cells by extracellular matrices. Exp Nephrol. 3:1995;362-368.
11. Thyberg J., Hultgardh N. A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 276:1994;263-271.
12. Herman I. M. Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin. Haemostasis. 1:1990;166-177.
13. Roman J., McDonald J. A. Expression of fibronectin, the integrin alpha 5, and alpha-smooth muscle actin in heart and lung development. Am J Respir Cell Mol Biol. 6:1992;472-480.
14. van Dinther-Janssen A. C., Kraal G., van Soesbergen R. N., Scheper R. J., Meijer C. J. Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining layer. Implications for synovial lining cell destruction. J Rheumatol. 21:1994;1998-2004.
15. Lazenby A. J., Crouch E. C., McDonald J. A., Kuhn C. I. I. I. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis. 142:1990;206-214.
16. Masferrer J. L., Seibert K. Regulation of prostaglandin synthesis by glucocorticoids. Receptor. 4:1994;25-30.
17. Stewart A. G., Tomlinson P. R., Wilson J. Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs. Trends Pharmacol Sci. 14:1993;275-279.
18. Persson C. G. The action of beta-receptors on microvascular endothelium: or is airway plasma exudation inhibited by beta-agonists? Life Sci. 52:1993;2111-2121.
19. Lassalle P., Delneste Y., Gosset P., Gras M. H., Wallaert B., Tonnel A. B. T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur J Immunol. 23:1993;796-803.
20. Westendorp R. G., Draijer R., Meinders A. E., van Hinsbergh V. W. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. J Vasc Res. 31:1994;42-51.
21. Laszlo F., Whittle B. J., Evans S. M., Moncada S. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol. 283:1995;47-53.
22. Abdih H., Kelly C. J., Bouchier H. D. Nitric oxide (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury. J Surg Res. 57:1994;39-43.
23. Suttorp N., Hippenstiel S., Fuhrmann M., Krull M., Podzuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol. 270:1996;C778-C785.
24. Rosengren S., Bong G. W., Firestein G. S. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol. 154:1995;5444-5451.
25. Scott R. E. Differentiation, differentiation/gene therapy and cancer. Pharmacol Ther. 73:1997;51-65.
26. Hoshikawa Y., Kwon H. J., Yoshida M., Horinouchi S., Beppu T. Trichoststin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res. 214:1994;189-197.
27. Parsons P. G., Hansen C., Fairlie D. P. Tumor selectivity and transcription activation by azelaic bishydroxamic acid in human melanocytic cells. Biochem Pharmacol. 53:1997;1719-1724.
28. Gazit D., Ebner R., Kahn A. J., Derynck R. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol. 7:1993;189-198.
29. MacDonald I. M., Pannu R., Kovithavongs K., Peters C., Tredget E. E., Ghahary A. Effect of retinoic acid on expression of transforming growth factor-beta by retinal pigment epithelial cells in culture. Can J Ophthalmol. 30:1995;301-305.
30. Fairlie D. P., Abbenante G., March D. R. Macrocyclic peptidomimetics - forcing peptides into bioactive conformations. Curr Med Chem. 2:1995;654-686.
31. Jones J. I., Prevette T., Gockerman A., Clemmons D. R. Ligand occupancy of the alpha v beta 3 integrin is necessary for smooth muscle cells to migrate in response to insulin like growth factor i. Proc Natl Acad Sci USA. 93:1996;2482-2487.